| Date | Webinar Details | unique IPs |
| 1st – 22 Sep, 2022 | Prof. Alberto Papi | The role of anticholinersgics in asthma and asthma-COPD Overlap | Cancelled |
| 2nd – 20 Oct, 2022 | GSK Patient factors impacting asthma care:important considerations for moderate asthma management Prof. Lavoie, Prof. Fritscher, Prof. Roche |
1197 |
| 3rd – 17 Nov, 2022 | Prof. Alvaro A. Cruz for his speech on “Key messages to improve outcomes for people with asthma and COPD in low- and middle-income countries” | 698 |
| 4th – 22 Dec, 2022 | Prof. Guillermo Guidos Fogelbach | Impact of climate chnages on asthma | 489 |
| 5th – 19 Jan, 2023 | Prof. Angelica Tiotiu | Criteria to evaluate efficacy of biologics in asthma: a survey | 934 |
| 6th – 23 Feb, 2023 | Prof. Imran Satia |Chronic cough: is it asthma or something else: a practical approach? | 494 |
| 7th – 23 Mar, 2023 | GSK SABA reliever therapy: where does it fit in the evolving asthma management landscape? Prof. Garcia, Prof. Domingo, Prof. Vazquez |
1189 |
| 8th – 21 Apr, 2023 | Prof. Michael Weschler | From asthma pathophysiology to treatment of severe asthma: an overview of biologics | 532 |
| 9th – 02 May, 2023 | GSK Evolving strategies to personalise asthma treatment Prof. Canonica, Prof. Singh, Prof. Chapman |
1213 |
| 10th – 21 Sep, 2023 | Prof. Ansotequi | The global asthma burden! Is it increasing ? | 486 |
